https://www.selleckchem.com/pr....oducts/s-gsk1349572.
01) and height (p 0.01) were associated with risk of meningioma. When the data were stratified by sex, height remained a significant factor only in men. Spline analysis of the male subjects showed that a height of 1.62 m was associated with a minimum disease risk and a height of 1.85+ meters, with a significant risk. This large population study showed that sex and adolescent height in males ( 1.85 m) were associated with an increased risk of meningioma in adulthood. 1.85 m) were associated with an increased risk of mening